|Table of Contents|

Research progress in early screening of hepatocellular carcinoma by circulating tumor cells

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2022 06
Page:
1133-1137
Research Field:
Publishing date:

Info

Title:
Research progress in early screening of hepatocellular carcinoma by circulating tumor cells
Author(s):
QIN Yaqin
Nanning Fourth People's Hospital,Guangxi AIDS Clinical Treatment Center(Nanning),Guangxi Nanning 530023,China.
Keywords:
circulating tumor cells; early screening; HCC
PACS:
R735.7
DOI:
10.3969/j.issn.1672-4992.2022.06.039
Abstract:
This paper summarizes the limitations of the main serum indicators of hepatocellular carcinoma(HCC),the discovery of circulating tumor cells,the commonly used detection methods and their value in screening malignant tumors,especially the research progress of circulating tumor cells in the early diagnosis,prognosis evaluation,distant metastasis and recurrence of HCC in recent years,which is a new indicator of great clinical significance at present.

References:

［1］WANG F,FAN J,ZHANG Z,et al.The global burden of liver disease:The major impact of China［J］.Hepatology,2015,60(6):2099-2108.
［2］李秋林,余家华,容敏华,等.2014年广西肿瘤登记地区恶性肿瘤发病和死亡分析［J］.中国癌症防治杂志,2018,10(1):29-37. LI QL,YU JH,RONG MH,et al.Analysis of the incidence and death of malignant tumors in Guangxi cancer registration area in 2014 ［J］.China Journal of Cancer Control,2018,10(1):29-37.
［3］马良,苏丹柯,肖晓兰,等.广西壮族自治区某肿瘤医院2007年-2016年恶性肿瘤住院患者疾病谱分析［J］.中国病案,2018,19(5):62-66. MA L,SU DK,XIAO XL,et al.Disease spectrum analysis of cancer inpatients in a Cancer Hospital of Guangxi Zhuang Autonomous Region from 2007 to 2016 ［J］.Chinese Medical Record,2018,19(5):62-66.
［4］AHN DG,KIM HJ,KANG H,et al.Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea［J］.Korean J Intern Med,2016,31(1):46-53.
［5］侯玉丽,姜菲菲,王颖,等.AFP在早期肝癌诊断中的临床价值研究［J］.中国现代医学杂志,2018,28(5):92-96. HOU YL,JIANG FF,WANG Y,et al.Study on the clinical value of AFP in the diagnosis of early liver cancer ［J］.Chinese Journal of Modern Medicine,2018,28(5):92-96.
［6］丰先明.甲胎蛋白异质体在乙型肝炎病毒相关肝癌中的临床价值［J］.检验医学与临床,2018,15(12):1820-1823. FENG XM.The clinical value of alpha fetoprotein heterogeneity in hepatitis B-related liver cancer ［J］.Laboratory Medicine and Clinical,2018,15(12):1820-1823.
［7］丁鹏鹏,田雅茹,林芳,等.AFP、AFP-L3、AFP-L3%和IL-6在乙肝肝硬化人群中诊断肝癌的价值［J］.医学研究杂志,2017，46(11):24-27. DING PP,TIAN YR,LIN F,et al.AFP,AFP-L3,AFP-L3% and IL-6 were diagnosed in patients with hepatitis B cirrhosis［J］.Journal of Medical Research,2017，46(11):24-27.
［8］袁星星,姜菲菲,贾泳梅,等.血清铁蛋白和甲胎蛋白及甲胎蛋白异质体-L3单项与联合检测对原发性肝癌辅助诊断的临床应用价值［J］.中华检验医学杂志,2016,39(8):604-608. YUAN XX,JIANG FF,JIA YM,et al.Single and combined detection of serum ferritin,alpha fetoprotein and alpha fetoprotein isomer-L3［J］.Chinese Journal of Laboratory Medicine,2016,39(8):604-608.
［9］PANTEL K,ALIXPANABIRES C.Functional studies on viable circulating tumor cells［J］.Clinical Chemistry,2016,62(2):328-334.
［10］ASHWORTH T.A case of cancer in which cells similar to those in the tumours were seen in the blood after death［J］.The Australian Medical Journal,2009,3(14):146-149.
［11］吴剑龙,曹明溶.循环肿瘤细胞在原发性肝癌中的应用及展望［J］.临床医药文献电子杂志,2017,4(66):13052-13054. WU JL,CAO MR.Application and Prospect of circulating tumor cells in primary liver cancer ［J］.Electronic Journal of Clinical Medicine,2017,4(66):13052-13054.
［12］VO JH,NEI WL,HU M,et al.Comparison of circulating tumour cells and circulating cell-free Epstein-Barr virus DNA in patients with nasopharyngeal carcinoma undergoing radiotherapy［J］.Sci Rep,2016,6(1):13-14.
［13］HE C,HUANG X,SU X,et al.The association between circulating tumor cells and Epstein-Barr virus activation in patients with nasopharyngeal carcinoma［J］.Cancer Biology & Therapy,2017，18（11）：888-894.
［14］张敬剑.晚期肿瘤患者503例循环肿瘤细胞阳性率分析［J］.肿瘤学杂志,2018,24(5):516-517. ZHANG JJ.Analysis of the positive rate of circulating tumor cells in 503 patients with advanced cancer ［J］.Journal of Ooncology,2018,24(5):516-517.
［15］YANG Y，IOI J，JIN L，et al．Independent correlation between ki67 index and circulating tumor cells in the diagnosis of coloreetal caneer［J］．Anticancer Res，2017，37(8)：4693-4700．
［16］CUI CH，CHEN RH，ZHAI DY，et al．Detection of FAMl72A expressed in circulating tumor cells is a feasible method to predict high-risk subgroups of coloreetal cancer［J］．Tumour Bidl，2017，39(6)：1010-1013.
［17］SONN CH，CHO JH，KIM JW，et al．Detection of circulating tumor cells in patients with non-small cell lung cancer using a size-based platform［J］．Oncol Lett，2017，13(4)：2717-2722．
［18］VONA G，SABILE A，LOUHA M，et al.Isolation by size of epithelial tumor cells： a new method for the immunomorphological and molecular characterization of circulatingtumor cells［J］.Am J Pathol，2000，156（1）：57-63.
［19］ZHENG S，LIN HK，LU B，et al.3D microfilter device for viable circulating tumor cell （CTC） enrichment from blood［J］.Biomed Microdevices，2011，13（1）：203-213
［20］ZHANG Y,LI J,CAO L,et al.Circulating tumor cells in hepatocel-lular carcinoma:detection echniques clinical imply cations and future perspectives［J］.Seminars in Oncology,2012,39(4):449-460.
［21］XU W，CAO L，CHEN L，et al.Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy［J］.Clin Cancer Res，2011，17（11）：3783-3793.
［22］穆洪，林凯璇，赵宏，等.肝细胞肝癌外周血循环肿瘤细胞的检测［J］.中华肿瘤杂志，2014，36（4）：276-281. MU H,LIN KX,ZHAO H,et al.Detection of tumor cells in peripheral blood circulation of HCC［J］.Chinese Journal of Cancer,2014,36(4):276-281.
［23］曹旻璐，沈敏娜，周琰，等.qRT-PCR平台和CellSearch系统检测肝细胞肝癌患者循环肿瘤细胞性能比较［J］.检验医学，2019，34（10）：927-931. CAO ML,SHEN MN,ZHOU Y,et al.qRT-PCR platform and CellSearch system were used to detect circulating tumor cells in patients with HCC［J］.Laboratory Medicine,2019,34(10):927-931.
［24］欧洋,高德海,王振丹,等.CTC-Biopsy系统检测肿瘤患者外周血CTC 临床应用可行性研究［J］.中华肿瘤防治杂志，2019，26（1）：56-60. OU Y,GAO DH,WANG ZD,et al.The feasibility study of clinical application of CTC biopsy system in detecting peripheral blood CTC of tumor patients［J］.Chinese Journal of Cancer Control,2019,26(1):56-60.
［25］中国研究型医院学会微创外科学专业委员会.循环肿瘤细胞检测在肝细胞肝癌中的研究应用现状专家共识(2019) ［J］.中华腔镜外科杂志(电子版)，2019，12（4）：193-198. Committee of Minimally Invasive Surgery,Chinese Society of Research Hospitals.Application of circulating tumor cell detection in hepatocellular carcinoma.Expert consensus on research and application status(2019) ［J］.Chinese Journal of Endoscopic Surgery(Electronic Edition),2019,12(4):193-198.
［26］齐鲁楠，向邦德，吴飞翔,等.肝细胞癌患者循环血肿瘤细胞的检测、分型鉴定及其临床意义［J］.中国癌症防治杂志,2017，9(1)：55-60. QI LN,XIANG BD,WU FX,et al.Detection,classification and clinical significance of circulating blood tumor cells in patients with HCC ［J］.Chinese Journal of Cancer Prevention and Treatment,2017,9(1):55-60.
［27］朱莉敏，纪莉.超声引导下射频消融治疗肝癌的疗效及血清CTC、HGF水平变化研究［J］.海南医学，2021，32（7）：831-834. ZHU LM,JI L.Study on the efficacy of ultrasound-guided radiofrequency ablation in the treatment of liver cancer and the changes of serum CTC and HGF levels ［J］.Hainan Medicine,2021,32(7):831-834.
［28］何泳铸,何坤,叶少炜，等.肝癌肝移植术前循环肿瘤细胞检测的预后价值［J］.中华器官移植杂志，2021，42（2）：75-81. HE YZ,HE K,YE SW,et al.Prognostic value of circulating tumor cell detection before liver transplantation for hepatocellular carcinoma ［J］.Chinese Journal of Organ Transplantation,2021,42(2):75-81.
［29］赵振坤，倪莎，张震，等.恶性实体瘤治疗间期循环肿瘤细胞检测的初步探讨［J］.诊断病理学杂志，2019，26(2):112-116. ZHAO ZK,NI S,ZHANG Z,et al.A preliminary study on the detection of tumor cells in the treatment of malignant solid tumors［J］.Journal of Diagnostic Pathology,2019,26(2):112-116.
［30］石军,叶光强,柯雨尼,等.用SE-iFISH技术检测肝细胞癌患者外周血循环中的肿瘤细胞［J］.中华普通外科杂志，2018，33（10）：865-868. SHI J,YE GQ,KE YN,et al.The tumor cells in the peripheral blood circulation of patients with HCC were detected by SE-iFISH technique［J］.Chinese Journal of General Surgery,2018,33(10):865-868.
［31］LIU S,LI N,YU X,et al.Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells［J］.Gastroenterology,2013,144(5):1031-1041.
［32］肖晗,余宏铸.循环肿瘤细胞在原发性肝细胞肝癌患者中预后预测价值的meta分析［J］.肝胆外科杂志,2017,25(2):98-102. XIAO H,YU HZ.Meta analysis of prognostic value of circulating tumor cells in patients with primary liver cancer ［J］.Journal of Hepatobiliary Surgery,2017,25(2):98-102.
［33］HUANG JW,LIU B,HU BS,et al.RETRACTED ARTICLE:Clinical value of circulating tumor cells for the prognosis of postoperative transarterial chemoembolization therapy［J］.Medical Oncology,2014,31(9):175-179.
［34］JIN J,NIU X,ZOU L,et al.AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis［J］.Cancer Letters,2016,378(1):33-37.
［35］李磊.肿瘤循环细胞检测预测肝癌术后复发的临床研究［J］.现代肿瘤医学，2016，24（16）：2554-2556. LI L.The clinical study of the detection of tumor circulating cells to predict the recurrence of liver cancer after operation［J］.Modern Oncology,2016,24(16):2554-2556.
［36］何泳铸，何坤，王泽亮，等.肝细胞癌术前循环肿瘤细胞与微血管侵犯关系的临床研究［J］.肿瘤研究与临床，2021，33（4）：276-281. HE YZ,HE K,WANG ZL,et al.Clinical study on the relationship between circulating tumor cells and microvascular invasion before hepatocellular carcinoma surgery ［J］.Cancer Research and Clinic,2021,33(4):276-281.
［37］张振毫.循环肿瘤细胞检测对结直肠癌患者根治术后异时性肝转移的预测价值分析［J］.解放军医药杂志，2018，30（6）：18-21. ZHANG ZH.Analysis of the predictive value of circulating tumor cells in patients with heterochronous liver metastasis after radical resection of colorectal cancer［J］.Journal of PLA Medicine,2018,30(6):18-21.
［38］万磊，陈佳佳，刘建军，等.原发性肝癌患者CTCs与CD4+／CD8+、NLR、TTV及肿瘤分期的相关性研究［J］.中国病理生理杂志，2016，32(6):1017-1021. WAN L,CHEN JJ,LIU JJ,et al.Study on the correlation between CTC,CD4+ / CD8+,NLR,TTV and tumor stage in patients with primary liver cancer［J］.Chinese Journal of Pathophysiology,2016,32(6):1017-1021.
［39］王喜术，孙玉春，李延军，等.肝癌患者循环肿瘤细胞表型与临床病理特征的相关性研究［J］.局解手术学杂志，2019，28（3）：233-238. WANG XS,SUN YC,LI YJ,et al.The correlation between the phenotype of circulating tumor cells and clinicopathological characteristics in patients with liver cancer［J］.Journal of Local Surgery,2019,28(3):233-238.
［40］何泳铸，叶少炜，刘立文，等.循环肿瘤细胞对肝癌射频消融术后复发的预测价值［J］.中华普通外科学文献（电子版），2021，15（2）：137-141. HE YZ,YE SW,LIU LW,et al.Predictive value of circulating tumor cells for recurrence of hepatocellular carcinoma after radiofrequency ablation ［J］.Chinese Journal of General Surgery,2021,15(2):137-141.
［41］何坤，何泳铸，胡泽民，等.肝癌射频消融术后复发危险因素分析及术前预测评分［J］.中华肝胆外科杂志，2021，27（3）：169-174. HE K,HE YZ,HU ZM,et al.Analysis of risk factors for recurrence of liver cancer after radiofrequency ablation and preoperative predictive score ［J］.Chinese Journal of Hepatobiliary Surgery,2021,27(3):169-174.
［42］陈明，王旭林，邢人伟，等.早期肝癌患者细胞免疫功能、血清VEGF表达及CTC微转移与术后复发的相关性［J］.重庆医学，2020，49（3）：356-359,364. CHEN M,WANG XL,XING RW,et al.Correlation of cellular immune function,serum VEGF expression and CTC micrometastasis with postoperative recurrence in patients with early hepatocellular carcinoma ［J］.Chongqing Medicine,2020,49(3):356-359,364.

Memo

Memo:
-
Last Update: 1900-01-01